Adam BohrAdam Bohr, PhD is the CEO and co-founder of Sonohaler, an mhealth and medical device company focused on asthma management using acoustic signals and machine learning tools. He is also a co-founder of Zerion ApS, a pharmaceutical company aspiring to tansform the pharmaceutical landscape for formulation of poorly soluble drugs. Previously, he was employed as assistant professor at the Department of Pharmacy, University of Copenhagen where he was doing research on drug implants, nanomedicine and microfluidic technology and teaching pharmaceutical technology subjects. He has published more than 45 peer reviewed academic papers and book chapters and has a PhD in Biomedical Engineering from University College London. He is a health futurist and a healthcare AI proponent with a passion for patient centered healthcare technologies. Read More Read Less